Dynavax Technologies (DVAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
Assets | |||||
Current Assets | |||||
Cash & Cash Equivalents | 150,279 | 202,004 | 436,189 | 32,073 | 39,884 |
Marketable Securities | 592,023 | 422,391 | 109,761 | 132,963 | 111,171 |
Receivables | 44,533 | 147,515 | 131,816 | 22,661 | 8,886 |
Inventories | 53,290 | 59,446 | 61,335 | 63,689 | 41,332 |
TOTAL | $859,120 | $916,985 | $972,520 | $290,015 | $208,653 |
Non-Current Assets | |||||
PPE Net | 37,297 | 37,596 | 35,020 | 30,567 | 32,022 |
Intangibles | 2,067 | 2,006 | 2,125 | 2,297 | 4,581 |
Other Non-Current Assets | 98,612 | 29,263 | 29,581 | 30,393 | 33,812 |
TOTAL | $137,976 | $68,865 | $66,726 | $63,257 | $70,415 |
Total Assets | $997,096 | $985,850 | $1,039,246 | $353,272 | $279,068 |
Liabilities | |||||
Current Liabilities | |||||
Accounts payable and accrued liabilities | 5,245 | 3,211 | 2,600 | 3,312 | 9,278 |
Accrued Expenses | 52,430 | 35,494 | 54,484 | 21,904 | 18,922 |
Other current liabilities | 4,520 | 111,369 | 149,454 | 13,983 | 24,847 |
TOTAL | $62,195 | $150,074 | $556,402 | $77,411 | $53,047 |
Non-Current Liabilities | |||||
Long Term Debt | 29,720 | 32,801 | N/A | 179,811 | 178,601 |
Deferred Revenues | N/A | N/A | 349,864 | 38,212 | N/A |
Other Non-Current Liabilities | 283,109 | 221,962 | 260,470 | 37,357 | 39,130 |
TOTAL | $312,829 | $254,763 | $260,470 | $217,168 | $217,731 |
Total Liabilities | $375,024 | $404,837 | $816,872 | $294,579 | $270,778 |
Shareholders' Equity | |||||
Shares Outstanding, K | 130,615 | 127,687 | 124,922 | 113,256 | 86,189 |
Common Shares | 130 | 128 | 123 | 110 | 84 |
Retained earnings | -930,584 | -924,195 | -1,217,351 | -1,294,064 | -1,218,824 |
Other shareholders' equity | -2,108 | -5,438 | -2,266 | 273 | -2,387 |
TOTAL | $622,072 | $581,013 | $222,374 | $58,693 | $8,290 |
Total Liabilities And Equity | $997,096 | $985,850 | $1,039,246 | $353,272 | $279,068 |